Full-Time
Healthcare Outside Sales Associate
San Antonio
Privia Health
1,001-5,000 employees
Physician groups optimized for value-based payments
Compensation Overview
$60k - $65k/yr
San Antonio, TX, USA
Hybrid
Requires 70–80% regional travel across Arizona, California, Texas, Washington, and Montana.
Bachelor's
 Sales & Account Management (1) |
|---|
Get referred to Privia Health
See people who can refer or advise you
- At least 2 years of experience selling products or services in a professional setting.
- Strong objection management and sales techniques are preferred.
- Experience with customer relationship management software such as Salesforce.com is preferred.
- Reliable transportation is required.
- Must comply with HIPAA rules and regulations.
- Generate new-business leads and conduct in-person prospecting with independent physician practices, representing approximately 70% of the role.
- Qualify opportunities with the goal of setting qualified appointments.
- Manage a quota and follow up with interested physicians, managing opportunities through close.
- Track activities, leads, and pending deals in Salesforce customer relationship management software and participate in weekly sales meetings and calls with internal and external teams.
- Collaborate with in-office Growth Operations Associates to gather intelligence, research, and qualify prospects.
- Help segment a market or region with the Director to further develop a target list of independent primary care practices.
- Develop strategies to maximize the company's presence in-market.
- Contribute new ideas and share best practices with the national sales team.
- Create relationships with potential partners.
- Follow through with communications to prospects.
- Work with Sales and Marketing constituencies to drive lead generation with top accounts and new opportunities.
- Travel regionally 70–80% across Arizona, California, Texas, Washington, and Montana.
- A bachelor's degree is preferred.
- Strong objection management and sales techniques are preferred.
- Experience with customer relationship management software such as Salesforce.com is preferred.
Privia Health is a national physician organization that aligns reimbursements with quality and outcomes to transform the healthcare delivery experience for providers and consumers. It partners with health plans, health systems, and employers to cut unnecessary costs, improve outcomes, and boost patient health. The company runs a platform built on physician leadership development, scalable systems, and proprietary technology to organize and scale physician groups into high-performance networks, reducing administrative burdens and giving doctors autonomy while supporting growth. Its approach centers on capital-efficient physician alignment models that enable expansion and closer coordination among providers, payers, and employers. By focusing on outcomes and efficiency rather than volume, Privia Health aims to lower costs, improve care quality, and empower clinicians.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Alexandria, Virginia
Founded
2007
Get referred to Privia Health
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q2 2026 revenue hit $632.6 million, up 21.4%, and guidance rose August 6.
- Implemented providers reached 5,644 and attributed lives hit 1.647 million in Q2.
- Opella Ernest joined the board August 18, strengthening compliance and value-based-care oversight.
What critics are saying
- CMS shared savings payment timing can delay cash, pressuring 2026 free cash flow.
- Payer consolidation squeezes reimbursement rates and weakens Privia’s margin expansion.
- If physician recruiting slows, 2027 growth stalls and the platform story breaks.
What makes Privia Health unique
- Privia Health owns physician-led governance and scaled networks across 25 states.
- Its Privia Platform bundles reimbursement, analytics, and population-health workflows.
- The New Jersey launch with NGBC shows repeatable market-entry execution.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
401(k) Retirement Plan
Paid Vacation
Wellness Program
Performance Bonus
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↑ 0%Privia Health announces appointment of Opella Ernest, M.D. to its Board of Directors. MWN-AI** Summary. Privia Health Group, Inc. has announced the appointment of Dr. Opella Ernest to its Board of Directors, effective September 1, 2026. Dr. Ernest's appointment is expected to enhance Privia Health's strategic direction, particularly as the company continues to expand its provider networks across the United States. David King, Chairman of the Board, expressed enthusiasm for Dr. Ernest's extensive clinical expertise and value-based care experience, which aligns with Privia's mission to improve healthcare delivery. With over 20 years of healthcare executive experience, Dr. Ernest currently serves as President of HCSC Markets at Health Care Service Corporation, where she oversees strategic direction and performance across all market segments. Her previous roles include Executive Vice President and COO at HCSC, during which she spearheaded technology-driven enhancements to customer and provider experiences. Prior to her tenure at HCSC, she held leadership positions at Healthspring and various clinical practices. Dr. Ernest is a board-certified family physician, having earned her medical degree from The Ohio State University College of Medicine and a bachelor's degree from the University of Michigan. Beyond her corporate roles, she actively participates on the boards of World Business Chicago and the Museum of Science and Industry. She has also served as chair of the American Heart Association's Metro Chicago board, receiving the 2021 Heart of Gold Award for her contributions to addressing health issues. Privia Health is recognized as a leading physician enablement company, operating in 25 states and the District of Columbia. The company focuses on building robust provider networks and optimizing the practices of over 1,300 physicians, aiming to enhance patient care and lower costs while promoting the health and well-being of communities. MWN-AI** Analysis. Privia Health Group, Inc. (Nasdaq: PRVA) has recently announced the appointment of Dr. Opella Ernest to its Board of Directors, signifying a strategic move that could potentially enhance the company's operational efficacy and market position. Dr. Ernest brings over 20 years of healthcare executive experience, notably in value-based care and clinical operations, which aligns seamlessly with Privia's mission to optimize healthcare delivery. Dr. Ernest's previous role as President of HCSC Markets underscores her capacity to drive growth and innovation through technology, a critical component for companies navigating the evolving healthcare landscape. Her experience in transforming customer and provider experiences could prove invaluable as Privia continues to expand its scaled provider networks. For investors, this appointment indicates a commitment to enhancing management expertise, offering confidence in the future direction of the company. Privia Health operates as one of the nation's largest physician enablement companies, serving an extensive network of over 1,300 physician practices and impacting more than 6.1 million patients. The company's strategic emphasis on building strong partnerships across medical groups and health plans positions it well for sustainable growth amid increasing demand for cost-effective healthcare solutions. From a market perspective, this development could signal an uptick in stock performance as investor sentiment may positively react to enhanced leadership and strategic growth initiatives. However, potential investors should remain cognizant of the inherent risks associated with healthcare investments - including regulatory changes, competitive pressures, and market fluctuations. As Privia Health continues to leverage technology and leadership to improve health outcomes and provider well-being, investors would do well to monitor the execution of Dr. Ernest's initiatives and overall corporate performance in the dynamic healthcare sector. **MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release. August 18, 2026 09:00:00 am ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) - Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026. She has also been named a member of the Compliance Committee of the Board. "We are excited to welcome Dr. Ernest to our Board of Directors," said David King, Chairman of the Board, Privia Health Group, Inc. "She brings valuable clinical expertise and value-based care experience to the Board and her deep healthcare expertise will be beneficial to Privia Health as we continue to grow our business and build scaled provider networks across the United States." Dr. Ernest has over 20 years of healthcare executive experience. Since 2023, she has served as President, HCSC Markets at Health Care Service Corporation, responsible for the strategic direction, clinical operations, performance, and growth for all market segments. She served as Executive Vice President, Chief Operating Officer at HCSC from 2021 to 2023, transforming HCSC's customer and provider experience through advancements in technology and innovation. Prior to joining HCSC in 2012, Dr. Ernest held leadership roles at Healthspring and in various clinical practices. A board-certified family physician, Dr. Ernest has a degree in medicine from The Ohio State University College of Medicine and a bachelor's degree from the University of Michigan. Dr. Ernest is a member of the boards of directors of World Business Chicago and the Museum of Science and Industry. She is the former Chair of the American Heart Association's Metro Chicago board of directors and received the 2021 Heart of Gold Award for her dedication addressing health issues. About Privia Health Privia Health(TM) is one of the largest physician enablement companies in the United States with a presence in 25 states and the District of Columbia. Privia builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. Privia collaborates with medical groups, health plans and health systems to optimize 1,300+ physician practices, improve the patient experience for 6.1+ million patients, and reward 5,600+ physicians and advanced practitioners for delivering high-value care. Privia's mission is to transform healthcare delivery to achieve better outcomes, lower costs, and improve the health of communities and the well-being of providers. For more information, visit priviahealth.com and connect with Market Wire News on LinkedIn. Safe Harbor Statement This release may contain forward-looking statements within the meaning of the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the Company's control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in filings with the Securities and Exchange Commission ("SEC"), including those under "Risk Factors" therein. Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Forward-looking statements speak only as of the date made. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Contact: Robert Borchert SVP, Investor & Corporate Communications [email protected] 817.783.4841 FAQ**. How will the appointment of Dr. Opella Ernest to the Board of Privia Health Group Inc. (PRVA) influence the company's strategic direction and growth in value-based care? Dr. Opella Ernest's appointment to the Board of Privia Health Group Inc. (PRVA) is expected to enhance the company's strategic direction and growth in value-based care by leveraging her extensive experience in healthcare management and innovation in patient-centered solutions. With Dr. Ernest's extensive background in clinical operations, how does Privia Health Group Inc. (PRVA) plan to leverage her expertise to enhance its provider networks? Privia Health Group Inc. (PRVA) plans to leverage Dr. Ernest's extensive background in clinical operations to optimize and expand its provider networks through improved operational efficiencies, enhanced quality of care, and strategic partnerships. Can Privia Health Group Inc. (PRVA) provide insights into how Dr. Ernest's experience will impact its mission to improve healthcare delivery and outcomes for patients? Dr. Ernest's experience is likely to enhance Privia Health Group Inc.'s mission by leveraging his expertise to optimize healthcare delivery and patient outcomes through innovative strategies and improved operational efficiencies. What specific initiatives does Privia Health Group Inc. (PRVA) envision under Dr. Ernest's leadership on the Compliance Committee to ensure adherence to healthcare regulations? Privia Health Group Inc., under Dr. Ernest's leadership on the Compliance Committee, aims to enhance adherence to healthcare regulations through robust compliance training programs, automated monitoring systems, and regular audits to ensure ethical practices and regulatory alignment. **MWN-AI FAQ is based on asking OpenAI questions about Privia Health Group Inc. (NASDAQ: PRVA).
Privia Health reported second-quarter revenue of $632.6 million, beating analyst estimates by 5.9% with 21.4% year-on-year growth. However, adjusted earnings per share of $0.19 missed expectations of $0.24 by 22.2%. CEO Parth Mehrotra attributed strong performance to robust provider signings and expanded value-based attributed lives, with implemented provider growth of 10.1% and value-based attributed lives growth of 19.2%. The company's operating margin improved to 1.9%, up from 0.6% in the same quarter last year. During the earnings call, analysts questioned management about potential delays in CMS shared savings payments, confidence in reaching long-term EBITDA margin targets, and the company's AI deployment across billing and clinical workflows. Management described recent acquisitions of Evolent and IMS as progressing well.
Privia Health reported strong second-quarter 2026 results during its earnings call on 6 August. The healthcare company achieved 10.1% year-over-year growth in implemented providers and 19.2% growth in value-based attributed lives, driving total practice collections up 12.4%. Adjusted EBITDA increased 29% compared to the prior year, with EBITDA margin expanding 310 basis points as a percentage of care margin. CEO Parth Mehrotra highlighted strong new provider signings across all markets, providing visibility through 2026 and into next year. The company executed well across all business aspects during the quarter. CFO David Mountcastle discussed financial results and updated 2026 guidance, though specific figures were not detailed in the preliminary results announced before filing the Form 10-Q.
Privia Health Group reported second-quarter 2026 sales of US$632.63 million and net income of US$9.05 million, both up year-on-year. Management raised full-year GAAP revenue guidance to the top end of its prior US$2.35–US$2.45 billion range. The physician-enablement company has expanded into 25 states plus Washington, D.C., serving over 1.64 million attributed lives. Despite the positive results and raised guidance, investors face risks from rising healthcare labour costs and potential margin pressure from payer consolidation. The company's growth narrative projects US$3.0 billion revenue by 2029, requiring 10.1% annual revenue growth. Privia Health Group's shares fell 5.2% following the announcement.
Privia Health (NASDAQ: PRVA) raises full-year 2026 guidance Following strong Q2. 06 August 2026 11:22 AM PDT Summarize with AI You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to its research reports, in-depth technical and fundamental research. Learn more Privia Health Group Inc. achieved a net income of $9 million for the second quarter, marking a 237% increase from a year earlier. Despite this robust performance, shares fell 11.2% in recent trading, reflecting investor concerns about future growth prospects amidst broader market volatility. Key Highlights * The company achieved a total revenue of $632.6 million, a year-over-year increase of 21.4%. * In Q2 2026, Privia Health reported an adjusted EBITDA of $37.4 million, a 29.1% increase from $29.0 million the previous year. * Total revenues for the quarter reached $632.6 million, improving from $521.2 million, driven by increased practice collections amounting to $970 million, a 12.4% gain year-over-year. The company achieved a total revenue of $632.6 million, a year-over-year increase of 21.4%. The impressive performance underscores Privia's growth trajectory in the healthcare sector, despite a broader market response. Nonetheless, shares fell 11.2% to $21.28 in recent trading, raising questions about investor sentiment moving forward. By the Numbers In Q2 2026, Privia Health reported an adjusted EBITDA of $37.4 million, a 29.1% increase from $29.0 million the previous year. The company now operates with 5,644 implemented providers, reflecting a 10.1% growth compared to the same period last year. The performance metrics indicate that Privia is strengthening its market presence, with attributed lives increasing to 1.647 million, a strong 19.2% rise. Despite the positive figures, the stock's decline on the day suggests that investors are weighing future growth against market volatility, which may continue to impact share prices. Segment Detail Total revenues for the quarter reached $632.6 million, improving from $521.2 million, driven by increased practice collections amounting to $970 million, a 12.4% gain year-over-year. Gross profit rose to $128.9 million, up 14.3%, reflecting efficiency in operations. Even with significant year-over-year gains, share values dipped due to broader market apprehensions, highlighting potential investor caution regarding profitability and competition. This skepticism may influence future valuations, especially as operational costs continue to rise. Privia Health raised its full-year guidance across key financial metrics, indicating confidence in sustained growth. The company anticipates practice collections between $3.65 billion and $3.75 billion, and has adjusted its projected revenue higher to between $2.35 billion and $2.45 billion. This upward revision signifies management's belief in scaling operations and improving market penetration. Investors will likely scrutinize the upcoming conference call for qualitative insights on the strategies that will support this optimistic guidance and ongoing operational improvements. Market Reaction Following the earnings announcement, Privia's stock plummeted 11.2%, falling to $21.28. Since the beginning of the year, shares are down 9.3%, and 21.8% in the past month, indicating significant volatility. The market capitalization now stands at approximately $3 billion, with a 52-week range between $19.08 and $28.82. Sector peers reacted variably, with some posting gains while others faced declines, underscoring the mixed investor sentiment across the healthcare environment. The downward pressure on Privia's share price could impact its ability to fund future initiatives or investments as competitive pressures increase. Peers Moving on This News * RadNet Inc (RDNT) little changed * LifeStance Health Group Inc (LFST) up 4.7% * Option Care Health Inc (OPCH) down 1.3% Analysis based on company disclosures and public reporting. This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions. FAQs. Q: How did Privia Health's share price react to its earnings announcement? A: Following the announcement, Privia Health's shares dropped 11.2% to $21.28, which contrasts with the strong growth reported in earnings and revenue. Q: What does the revised guidance indicate for Privia Health's future? A: The raised full-year guidance suggests that Privia Health is confident about maintaining its growth trajectory, aiming for increased revenue and practice collections. However, investor concerns remain about market conditions. Download Free Report - Explore 3 Stock Ideas & Industry Insights Unlock 3 stock ideas and key industry insights in its free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice. All investments involve risk - consider independent advice before making any investment decisions. Disclaimer: